The Supreme Court of Louisiana Gives Choice of Pharmacy to Employers
The Supreme Court of Louisiana held that the employer, not the injured worker, gets to choose the pharmacy to furnish necessary prescription drugs. Prior to this case, the lower courts in Louisiana had been split on the question, with the Second and Fourth Circuits allowing an injured worker to choose the pharmacy, while the Third and Fifth Circuits allowed the employer to choose the pharmacy. The Supreme Court reasoned that La. R.S. 23:1121(B)(1) specifically states that the employee has the right to select one treating physician. But that selection does not extend to choice of pharmacy, as the legislature did not provide that in La. R.S. 23:1203(A).
The Supreme Court reasoned that unlike a patient’s personal relationship with his doctor, there is no meaningful difference relative to which pharmacy is used to dispense prescriptions. The court also reasoned that there were protections in place, including La. R.S. 23:1201(E), should the employer cause unreasonable delays or other deficiencies in filling prescriptions through the employer-chosen pharmacy.
The Supreme Court of Louisiana also held that pharmacies are subject to the $750 cap found in La. R.S. 23:1142(B) that requires a health care provider to have the consent of the employer and payer in order to receive payment in excess of $750 for non-emergency care. This affirms the Louisiana Supreme Court’s 2016 ruling in Lafayette Bone & Joint Clinic v. SIF. The Supreme Court reasoned that while the statutory language did not expressly include a reference to prescription medication, the word “treatment” in La. R.S. 23:1142(B) was sufficiently broad to include pharmacy dispensing of prescription medication.
Again, we at UR Nation believe this decision is big win for Louisiana system participants. We also believe this is a good decision because the employer controlling the choice of pharmacy further restricts an injured worker’s ability to “doctor shop” for opioids, benzodiazepines, and other addictive and potentially dangerous drugs.